- Home
- APLM vs POLA Comparison
APLM vs POLA Comparison
Compare APLM & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- POLA
- Stock Information
- Founded
- APLM 2016
- POLA 1979
- Country
- APLM United States
- POLA United States
- Employees
- APLM N/A
- POLA N/A
- Industry
- APLM Blank Checks
- POLA Industrial Machinery/Components
- Sector
- APLM Finance
- POLA Miscellaneous
- Exchange
- APLM Nasdaq
- POLA Nasdaq
- Market Cap
- APLM 6.9M
- POLA 5.6M
- IPO Year
- APLM N/A
- POLA 2016
- Fundamental
- Price
- APLM $6.41
- POLA $1.70
- Analyst Decision
- APLM
- POLA
- Analyst Count
- APLM 0
- POLA 0
- Target Price
- APLM N/A
- POLA N/A
- AVG Volume (30 Days)
- APLM 4.6K
- POLA 9.0K
- Earning Date
- APLM 08-13-2025
- POLA 08-13-2025
- Dividend Yield
- APLM N/A
- POLA N/A
- EPS Growth
- APLM N/A
- POLA N/A
- EPS
- APLM N/A
- POLA N/A
- Revenue
- APLM $198,000.00
- POLA $13,918,000.00
- Revenue This Year
- APLM $415.15
- POLA N/A
- Revenue Next Year
- APLM N/A
- POLA N/A
- P/E Ratio
- APLM N/A
- POLA N/A
- Revenue Growth
- APLM N/A
- POLA 8.08
- 52 Week Low
- APLM $4.47
- POLA $1.65
- 52 Week High
- APLM $35.98
- POLA $4.90
- Technical
- Relative Strength Index (RSI)
- APLM 51.61
- POLA 42.95
- Support Level
- APLM $5.34
- POLA $1.67
- Resistance Level
- APLM $6.70
- POLA $1.75
- Average True Range (ATR)
- APLM 0.52
- POLA 0.05
- MACD
- APLM -0.03
- POLA 0.01
- Stochastic Oscillator
- APLM 67.65
- POLA 57.14
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.